#Qutim 100 mg full#
#Qutim 100 mg registration#
#Qutim 100 mg plus#

Unless the Notes are called prior to maturity, on the Maturity Date, for each $1,000 Principal Amount, we will pay you the Final Settlement Value.

With respect to each Underlying, 100.00% of its Initial Value

#Qutim 100 mg plus#

If the Official Closing Price of each Underlying is at or above its Call Threshold on any Call Observation Date the Notes will be automatically called, and you will receive a cash payment, per $1,000 Principal Amount, equal to the Principal Amount plus the applicable Contingent Coupon on the corresponding Call Payment Date. The Maturity Date is subject to adjustment as described under “ Additional Terms of the Notes―Coupon Payment Dates, Call Payment Dates and Maturity Date” in the accompanying Stock-Linked Underlying Supplement. June 14, 2023, subject to adjustment as described under “ Additional Terms of the Notes―Valuation Dates” in the accompanying Stock-Linked Underlying Supplement. (Ticker: NKE) (each an “Underlying” and together the “Underlyings”) (Ticker: CRM), and the Class B common stock of NIKE, Inc. The following key terms relate to the offering of the Notes:

linked to the Reference Asset as described below. The purchaser of a Note will acquire a senior unsecured debt security of HSBC The terms described in this document shall control.Īn offering of Notes linked to the Reference Asset. If the terms of the Notes offered herebyĪre inconsistent with those described in the accompanying prospectus, prospectus supplement, or Stock-Linked Underlying Supplement, The accompanying prospectus, prospectus supplement, and Stock-Linked Underlying Supplement. The Notes will have the terms described in this document and See “Supplemental Plan of Distribution (Conflicts of Interest)” on page PS-17Ī single offering of Autocallable Contingent Income Barrier Notes. May pay varying underwriting discounts of up to 3.25% per $1,000 Principal Amount in connection with the distribution of the Notes On page PS-8 of this document for additional information. See “Estimated Initial Value” on page PS-4 and “Risk Factors” beginning The market value of the Notes at any time will reflect many factorsĪnd cannot be predicted with accuracy. The Estimated Initial Value of the Notes on the Pricingĭate is $896.20 per Note, which is less than the price to public. Supplement and page S-1 of the accompanying Stock-Linked Underlying Supplement. You should refer to “Risk Factors” beginning on page PS-8 of this document, page S-1 of the accompanying prospectus Investment in the Notes involves certain risks.

See “Supplemental Plan of Distribution (Conflicts of Interest)” on page PS-17 of this document. Unless we or our agent inform you otherwise in the confirmation of sale, this pricing supplement is being used in a market-making Of its affiliates or agents may use this pricing supplement in market-making transactions in any Notes after their initial sale. To other registered broker-dealers or will offer the Notes directly to investors. will purchase the Notes from us for distribution We have appointed HSBC Securities (USA) Inc., anĪffiliate of ours, as the agent for the sale of the Notes. Representation to the contrary is a criminal offense.

Or the adequacy of this document, the accompanying prospectus, prospectus supplement or Stock-Linked Underlying Supplement. (the “SEC”) nor any state securities commission has approved or disapproved of the Notes or passed upon the accuracy (each a “Note” and collectively the “Notes”) offered hereunder will not be listed on any securities exchange The Autocallable Contingent Income Barrier Notes In the Least Performing Underlying, and you will lose all or a portion of your principal amount.ģ year term if not called prior to maturityĪll payments on the Notes are subject to the credit risk of HSBC USA Inc.

#Qutim 100 mg full#

If the Notes are not called and the Least Performing Underlying declines by more than 40.00%, there is full exposure to declines Monthly Contingent Coupon payments at a rate of approximately 1.04167% (equivalent to 12.50% per annum), payable if the OfficialĬlosing Price of each Underlying on the applicable Observation Date is greater than or equal to 60.00% of its Initial ValueĬallable quarterly at the principal amount plus the applicable Contingent Coupon on any Call Observation Date on or after Decemberġ6, 2020 if the Official Closing Price of each Underlying is at or above its Call Threshold Linked to the Least Performing of the Common

#Qutim 100 mg registration#

Calculated in accordance with Rule 457(r) of the Securities Act of 1933, as amended.Ī registration fee of $64.51 was previously paid (Accession No.